171 related articles for article (PubMed ID: 23334598)
1. The interleukin 17 system in cortical lesions in focal cortical dysplasias.
He JJ; Li S; Shu HF; Yu SX; Liu SY; Yin Q; Yang H
J Neuropathol Exp Neurol; 2013 Feb; 72(2):152-63. PubMed ID: 23334598
[TBL] [Abstract][Full Text] [Related]
2. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
[TBL] [Abstract][Full Text] [Related]
3. Expression and cellular distribution of the interleukin 2 signaling system in cortical lesions from patients with focal cortical dysplasia.
Guo W; Zheng DH; Sun FJ; Yang JY; Zang ZL; Liu SY; Yin Q; Zhang CQ; Yang H
J Neuropathol Exp Neurol; 2014 Mar; 73(3):206-22. PubMed ID: 24487795
[TBL] [Abstract][Full Text] [Related]
4. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B).
Englund C; Folkerth RD; Born D; Lacy JM; Hevner RF
Acta Neuropathol; 2005 May; 109(5):519-33. PubMed ID: 15877232
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of fibroblast growth factor 13 in cortical lesions of the focal cortical dysplasia.
Wu K; Yue J; Shen K; He J; Zhu G; Liu S; Zhang C; Yang H
Brain Res Bull; 2021 Mar; 168():36-44. PubMed ID: 33285262
[TBL] [Abstract][Full Text] [Related]
7. The IL-1beta system in epilepsy-associated malformations of cortical development.
Ravizza T; Boer K; Redeker S; Spliet WG; van Rijen PC; Troost D; Vezzani A; Aronica E
Neurobiol Dis; 2006 Oct; 24(1):128-43. PubMed ID: 16860990
[TBL] [Abstract][Full Text] [Related]
8. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q
Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236
[TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
Zurolo E; Iyer A; Maroso M; Carbonell C; Anink JJ; Ravizza T; Fluiter K; Spliet WG; van Rijen PC; Vezzani A; Aronica E
Brain; 2011 Apr; 134(Pt 4):1015-32. PubMed ID: 21414994
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
[TBL] [Abstract][Full Text] [Related]
11. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb.
Yu S; Li S; Shu H; Zhang C; He J; Fan X; Yang H
Neuroreport; 2012 May; 23(7):407-11. PubMed ID: 22494998
[TBL] [Abstract][Full Text] [Related]
14. Focal Cortical Dysplasias: clinical implication of neuropathological classification systems.
Spreafico R; Blümcke I
Acta Neuropathol; 2010 Sep; 120(3):359-67. PubMed ID: 20607544
[TBL] [Abstract][Full Text] [Related]
15. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
Mühlebner A; Coras R; Kobow K; Feucht M; Czech T; Stefan H; Weigel D; Buchfelder M; Holthausen H; Pieper T; Kudernatsch M; Blümcke I
Acta Neuropathol; 2012 Feb; 123(2):259-72. PubMed ID: 22120580
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of TRPC5 in cortical lesions of the focal cortical dysplasia.
Xu GZ; Shu HF; Yue HY; Zheng DH; Guo W; Yang H
J Mol Neurosci; 2015 Mar; 55(3):561-9. PubMed ID: 25085710
[TBL] [Abstract][Full Text] [Related]
17. Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias.
Coras R; de Boer OJ; Armstrong D; Becker A; Jacques TS; Miyata H; Thom M; Vinters HV; Spreafico R; Oz B; Marucci G; Pimentel J; Mühlebner A; Zamecnik J; Buccoliero AM; Rogerio F; Streichenberger N; Arai N; Bugiani M; Vogelgesang S; Macaulay R; Salon C; Hans V; Polivka M; Giangaspero F; Fauziah D; Kim JH; Liu L; Dandan W; Gao J; Lindeboom B; Blümcke I; Aronica E
Epilepsia; 2012 Aug; 53(8):1341-8. PubMed ID: 22642611
[TBL] [Abstract][Full Text] [Related]
18. Cortical neuronal densities and lamination in focal cortical dysplasia.
Thom M; Martinian L; Sen A; Cross JH; Harding BN; Sisodiya SM
Acta Neuropathol; 2005 Oct; 110(4):383-92. PubMed ID: 16151726
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias.
Iyer A; Zurolo E; Spliet WG; van Rijen PC; Baayen JC; Gorter JA; Aronica E
Epilepsia; 2010 Sep; 51(9):1763-73. PubMed ID: 20345941
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression and Cellular Localization of P2X7R in Cortical Lesions of Patients With Focal Cortical Dysplasia.
Wei YJ; Guo W; Sun FJ; Fu WL; Zheng DH; Chen X; Li S; Zang ZL; Zhang CQ; Liu SY; Yang H
J Neuropathol Exp Neurol; 2016 Jan; 75(1):61-8. PubMed ID: 26671983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
